Language selection

Search

Patent 1055881 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1055881
(21) Application Number: 204982
(54) English Title: ELECTROLYTIC REDUCTION OF AROMATIC STEROIDS
(54) French Title: REDUCTION ELECTROLYTIQUE DE STEROIDES AROMATIQUES
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 204/52.3
(51) International Patent Classification (IPC):
  • C25B 3/00 (2006.01)
  • C07J 1/00 (2006.01)
  • C07J 17/00 (2006.01)
  • C07J 21/00 (2006.01)
  • C25B 3/04 (2006.01)
(72) Inventors :
  • JUNGHANS, KLAUS (Not Available)
(73) Owners :
  • SCHERING AKTIENGESELLSCHAFT (Not Available)
(71) Applicants :
(74) Agent:
(74) Associate agent:
(45) Issued: 1979-06-05
(22) Filed Date:
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract



Abstract of the Disclosure
.DELTA.2,5(10)-steroids, which are intermediates for the
preparation of valuable pharmaceutical products, are produced
from corresponding .DELTA.1,3,5(10)-steroids by electrolytically
reducing the latter in liquid ammonia in a divided cell in the
presence of an alkali metal salt of a strong acid having a pK
value of less than 5, or an undivided cell in the presence of
an alkali metal salt of a weak acid having a pK value from
5 to 32. For example, oestrone methyl ether is electrolyti-
cally reduced in ammonia in the presence of lithium perchlorate
in a divided cell to produce 3-methoxy-.DELTA.2,5(10)-oestradien-17.beta.-
-ol.


Claims

Note: Claims are shown in the official language in which they were submitted.



THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for producing a .DELTA.2,5(10)-steroid compris-
ing the step of reducing a corresponding .DELTA.1,3,5(10)-steroid by
electrolysis in liquid ammonia in a cell in the presence of an
alkali metal salt of an acid, provided that when said cell is a
divided cell the acid is a strong acid having a pK value of less
than 5 and when said cell is an undivided cell the acid is a
weak acid having a pK value from 5 to 32.
2. A process according to claim 1, wherein the alkali
metal salt of a strong acid is an alkali metal halide, tetrafluo-
borate, sulphate or perchlorate.
3. A process according to claim 2, wherein the alkali
metal is lithium, sodium or potassium.
4. A process according to claim 1, wherein the alkali
metal salt of a weak acid is an alkali metal salt of aniline,
hydrazine or alcohol or an alkali metal hydroxide.
5. A process according to claim 4, wherein the alkali
metal is lithium, sodium or potassium.
6. A process according to claim 1, wherein the elec-
trolysis is carried out in an undivided cell in the presence of
an alkali metal salt of a strong acid, having a pK value of less
than 5 and an alkali metal salt of a weak acid having a pK value
from 5 to 32.
7. A process according to claim 6, wherein the alkali
metal salt of a strong acid is an alkali metal halide, tetrafluo-
borate, sulphate or perchlorate.
8. A process according to claim 7, wherein the alkali
metal is lithium, sodium or potassium.
9. A process according to claim 1, 2 or 3, wherein
the electrode compartments in the divided cell are separated



by porous material or an ion-exchange membrane.
10. A process according to claim 1, 2 or 3, wherein
the electrolysis is operated at a current density within the
range of from 0.1 to 5 amperes/cm2.
11. A process according to claim 1, 2 or 3, wherein the
.DELTA.1,3,5(10)-steroid is a 3-alkyl, -cycloalkyl or -aralkyl ether
of a .DELTA.1,3,5(10)-3-hydroxy-triene of the oestrane, 18-methyl
oestrane, 19-nor-pregnane or 19-nor-cholestane series.
12. A process according to claim 1 or 2, wherein the
.DELTA.1,3,5(10)-steroid is oestrone methyl ether; 3-methoxy-
.DELTA.1,3,5(10),8-oestratetraen-17.beta.-ol; 3-methoxy-18-methyl-.DELTA.1,3,5(10),8-

oestratetraen-17-one; 3-methoxy-.DELTA.1,3,5(10)-pregnatrien-17.alpha.-ol-
20-ethylene-ketal; 3-methoxy-.DELTA.1,3,5(10),9(11)-oestratetraen-
17.beta.-ol; 3-ethoxy-17.alpha.-methyl-.DELTA.1,3,5(10)-oestratrien-17.beta.-ol; 3-
cyclohexyloxy-17.alpha.-vinyl-.DELTA.1,3,5(10)-oestratrien-17.beta.-ol; 3-
methoxy-19-nor-.DELTA.1,3,5(10)-cholestatriene; 3-methoxy-1-methoxy-
19-nor-20-cycloethylenedioxy-.DELTA.1,3,5(10)-pregnatriene; 3-methoxy-
17.alpha.,20; 20,21-bis-methylenedioxy-19-nor-.DELTA.1,3,5(10)-pregnatriene;
3-methoxy-17-ethylenedioxy-.DELTA.1,3,5(10)-oestratriene or 3-methoxy-
17.beta.-t-butoxy-.DELTA.1,3,5(10),9(11)-oestratetraene.



Description

Note: Descriptions are shown in the official language in which they were submitted.


~5~
; The invention relates to a process for producing
~ '5'(10)-steroids from corresponding ~1'3'5(10)-steroids by
; electrochemical reduction.
It is known that the electrolys:is of unsaturated
aromatic steroids in liquid ammonia in an undivided cell in
the presence of alkali or alkaline earth rnetal salts does ;~
indeed lead to the reduction of unsaturated ~roups, but the
aromatic part of the steroid molecule is not attacked (see
German Patent Publication No. 2,063llOl, published 22nd June
1972 to Dr. Klaus Junghans).
; The electrochemical reduction of aromatic steroids
to form the corresponding Q2r5(10)-steroids is also known (see
' German Patent Specification No. 1,266,300). In such process,
;l the electrolysis is carried out in methylamine or in another
alkylamine solvent. Ilowever, the process has the dlsadvantage
that the amine used as the solvent must, after the electrolysis,
~ be separated from the product by distillation under reduced
`~ pressure or precipitation with other liquids.
Because of the low conductivity of the reaction mix- `
- 20 ture, the consumption of current is very high, and there is a
correspondingly strong evolution of heat. ~owever, in carrying
.:
~' out the process on an industrial scaie the heat must be removed.

The present invention is based on the problem of dis-
., .
;l covering a process for the electrochèmical reduction of aromatic
steroids, in which the solvent can be separated from the product, ~;~
without great technical expenditure and less current consumption,
and thus no great evolution of heat.
The above problem is solved by carrying out the elec-
trolysis with a liquid ammonia solvent in a divided cell in the
,` l
presence of an alkali metal salt of a strong acid having a pK


value of less than 5 as the conductive salt, or in an undivided
,, ~ .. . .
, ,
,. . ~

,, -- 1 --
~ .
! ~ ~ . , .

' ~
~S~;81!~
cell in the presence of an a]kali me-tal salt containing anions
of a weak acid having a pK value of 5 to 32 as the con~uctive
salts.
Electrochemical reduction in liquid ammonia is des-

cribed for simple aromatic substances (see, Eor example, U.S. -
Patents Nos. 3,493,477 and 3,488,266), but the smooth electrolysis
of steroids having a complex structure and optionally substituted
by functional groups could not have been expected~ Is is also
surprising that the aromatic ring is reduced by working in
accordance with the process of German ~atent Publication ~o.
2/063,101, but in a divided cell ins-tead of an undivided cell,
or by using in an undivided cell, as conductive salts, alkali
metal salts having anions of acids that are weak acids in liquid
ammonia, optionally with the addition of alkali metal salt of
strong acids.
W'nen the elec-trolysis of the invention is carried out
in a divided cell, there are used as conductive salts alkali
metal salts, for example, lithium, sodium or potassium salts.
The anions necessary for charge equalization are derived from
strong acids and are, for example, halides such as a chloride or
bromide, or complex anions such as a tetrafluoborate, sulphate
or perchlorate.
When the electrolysis is carried out in an undivided
cell, there are used as conductive salts alkali salts of weak
` acids, for example, aniline, hydrazine~ alcohol or water in
liquid ammonia, i.e. alkali metal anilides, hydrazides, alcohol- ;
ates, and hydroxides.
The concentration ratio of electrolyte salt to the
steroid to be reduced has no influence on -the reduction and may
vary within wide limits. The reduction is also not disturbed if

; a portion of the reactants is present as solid at the bottom




-- 2
:.
.'..... . .,,, , . , . , ,, , ., :

~55~
.
of the liquid (saturated solution).
In accordance with the invention, ammonia is used as
solvent. Small amounts of other solvents may be added, provided
they are inert with respect to the reac-tants. Such other sol-
vents serve as a solubiliser between the ammonia and the steroid
to be reduced. The other solvents include, for example, ethers
such as diethyl ether, tetrahydrofuran and dioxane, acid deriva-
- tives such as ethyl acetate, acetonitrile and dimethylformamide,
and dimethyl sulphoxide.
The divided cell is of conventional construction, the
electrode compartments being separated by porous m~terial, for
example, glass frit, a clay diaphragm or asbestos wool, or by
an ion-exchange membrane.
The electrolysis may be carried out with an~ type of
current such as alternating current, rectified unsmoothed alter-
nating current, direct current or modulated direct current. The
;, conditions of the electrolysis, such as voltage, amperage, cur-
rent density, electrode area, pressure and temperature, can be
varied widely. It is advantageous to operate at a current den-
20 sity of 0.1 to 5 amperes/cm2 and a temperature of from -50C up
to the boiling point of the reaction mixture. ~Iowever, it is
also possible to operate under pressure. The nature of the
electrode material is not critical. It only has to conduct the
current and to be stable under the conditions of the electrolysis,
as are, for example, gold, silver, mercury, platinum, aluminium,
tungsten carbide and graphite. The process of electrolysis may
be carried out in a continuous or discontinuous manner. -
The starting compounds used in accordance with the
invention are ~1~3~5(1)-3-hydroxy-trienes of oestrane, 18-methyl-
30 oestrane, l9-nor-pregnane or l9-nor-cholestane in the form of


-3-
.. ''' .

5B8~

their 3-alkyl, 3-cycloalkyl or 3-aralkyl ethers. They may con-
tain, in addition -to the double bonds in the aromatic A-ring,
one or more conjugated carbon-to-carbon bonds such as, for
example, ~6_, ~8_, or a9 (11)_ and/or other reducible groupings,
for example, carbonyl groups in the 6-, 11- or 20-position,
nitro or imino groups ~C=N~, wherein R represents hydrogen,
hydroxyl, alkyl, aryl or aralkyl. The double bonds are co-
reduced during the process of the invention, and an exo-cyclic
multiple bond, such as the 17~-ethinyl group, is reduced to a
double bond. Such an isolated carbon-to-carbon double bond is
not further reduced. The steroid structure may contain addi-
tional alkyl groups, for example, methyl in the 1-, 6-, 7- or
16-position, and free or functionally convertedhydroxyl groups
in the 1-, 3-, 6-, 7-, 11-, 15-, 16-, 17-, or 21-position. A
17-alkyl group may be ~-or ~-positioned.
The starting steroids include, for example, oestrone
methyl ether; 3-methoxy-~1'3'5(1)'3-oestratetraen-17~-ol; 3-
methoxy-18-methyl-~1'3'5(1)'3-oestratetraen-17-one; 3-methoxy-
~ '3'5(1)-pregnatrien-17~-ol-20-ethylene-ketal; 3-methoxy-
~1~3'5'(10)'9(11)-oestratetraen-17~-ol; 3-ethoxy-17a-methyl-
oestra-~1'3'5(1)-trien-17~-ol; 3-cyclohexyloxy-17~-vinyl-
~1'3'5(1)-oestratrien-173-ol; 3-methoxy-19-nor-~1'3'5(1)-
chloestatriene; 3-methoxy-1-methyl-19-nor-20-cycloethylenedioxy-
'3'5(10)-pregnatriene; 3-methoxy-17~,20;20,21-bis-methylene-
dioxy-pregna-l9-nor-~1'3'5(10)-pregnatriene; 3-methoxy-17-
ethylene-diOxy-~1'3'5(10)-oestratriene and 3-methoxy-17~-t-
b t ~1,3,5(10),9(11)_Oestratetraene.
The compounds obtained by the process of the present
invention are often intermediate products fot the preparation of
i 30 valuable pharmaceutical products.
~"'"'
. ~
~, -ds ~

~3S5~8~L `
The present invention will be further illustrated by
way of the followiny Examples in which Examples 1, 4, 6, and 7
relate to divided cells.
Example 1
1.0 g of oestrone methyl ether is dissolved in 50 ml of
tetrahydrofuran and 200 ml of liquid ammonia, and the solution is
electrolyzed in the presence of 2.5 g of lithium perchlorate in a
cell divided by a glass frit for 1.5 hours at 1 ampere (cathode
of stainless steel and anode of graphite). After evaporating the
solvent, water is added, and the mixture is filtered. There is
thus obtained 0.9 g of 3-methoxy-~ ' (1)-oestradien-17~--ol melt-
ing at 114-116C (methanol~.
Example 2
2.0 g of 3-methoxy-~1'3'5(1)'3-oestratetraene-17~-ol
are eleckrolyzed in 200 ml of liquid ammonia and 20 ml of ethanol
in the presence of 2 g of lithium ethylate and 0.5 g of lithium C
anilide for 3 hours in an undivided cell between an aluminium
cathode and a platinum anode at a current density of 2.5 amperes/
cm . After working up, there are isolated 1.8 g of 3-methoxy-
~ '5(1~-oestradien-17~-ol melting at 110C.
Example 3 l~
0-5 g of d~l-3-methoxy-lg-methyl-~l~3~5(lo)~8 oest
; tetraen-17-one in 250 ml of liquid ammonia is electrolyzed in an
autoclave at 30C between a stainless steel cathode and a
graphite anode in the presence of 2.0 g of sodium chloride and
` 2.0 g of sodium ethylate at 2 amperes. When the reaction has
;, terminated, the solvent is evaporated by cautious pressure
equilization, water is added to the residue, and the mixture is L
filtered. There is thus obtained 0.4 g of _,1-3-methoxy-18-
methyl-h ' (1)-oestradien-17~-ol melting at 98-100C.
Example 4
- 1.0 g of 3-methoxy-hl'3'5(1)-pregnatrien-17a-ol-20-
ethylene-ketal is electrolyzed in a cell divided by a cation

-5-

exchange membrane in 200 ml of liquid ammonia in the presence
of 2.5 g of sodium perchlorate with an aluminium cathode. After
; working up, 1.0 g of 3-methoxy-Q2'5(1)-pregnadien-17~-ol-20- -
ethylene-ketal melting at 172-175C.

Example 5
1.0 g of 3-methoxy-~l~3~5(lO)~9(ll)-oestratetraen-17~-


-ol is dissolved in 25 ml of dioxane, and the solution is intro-
duced into a decolorized mixture of 0.5 g of lithium in 200 ml
of liquid ammonia, 5 g of lithium chloride, 15 ml of ethanol and
5 ml of aniline. When electrolysis at 1 ampere between two
platinum electrodes has terminated and the ammonia has been
evaporated, a large amount of water is added, and the mixture
; is filtered. 0.8 g of 3-methoxy-~2'5(1)-oestradien-173-ol
melting at 108-112C is isolated.
Example 6
1.0 g oE 3-methoxy-17-ethylene-dioxy-~1'3'5(1)-oestra-
triene in 10 ml of ethanol is added to 200 ml of liquid ammonia
and 2 g of lithium chloride, and electrolyzed for 1 hour at 1
ampere with a tungsten carbide electrode in a cell divided by
- 20 a cation exchange membrane. After working up, 0.9 g of 3-
methoxy-17-ethylene-dioxy-~2'5(1)-oestradiene melting at
115-120C is obtained.
Example 7
1.0 g of 3-methoxy-17 -t-butoxy-~1~3~5(10)~9(11) oe t
t~traen:i~sdissolved in 4 ml of aniline and 3 ml of ethanol,
added to 150 ml of liquid ammonia and 5 g of lithium perchlor~

.:
ate, and electrolyzed for 2 hours at 1 ampere with a merecury

~ electrode in a cell divided by a glass frit. After working up,


;, the crude product (1.1 g) is dissolved in ethanol and heat~d

-~ 30 with 3 ml of concentrated hydrochloric acid. By the cautious
.`~'''. .
:'

.: :

';, '

: addition of water and after cooling, 0.~ y of nor-testosterone ;:
is obtained which, after recrystallization from isopropyl ether, ;~
melts at 108-110C.
,. ~'.

.. . .
.-, .~, .':

. .

'....... , 10 .
;j"
... ,~
,,, ~

. D, ' :
.' . .

;~'.' ' ' ~

" ,"' '~ '
.~J

:i~
.. ''.',' ` ..


.. . .
.: .
.. . .

.,i ~


., ~
:- ....................................................................... .
.''` ~: ` .

:. 30

: . .
.,:;

~., -7-
:.
,

Representative Drawing

Sorry, the representative drawing for patent document number 1055881 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1979-06-05
(45) Issued 1979-06-05
Expired 1996-06-05

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
SCHERING AKTIENGESELLSCHAFT
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1994-04-22 1 13
Claims 1994-04-22 2 84
Abstract 1994-04-22 1 24
Cover Page 1994-04-22 1 31
Description 1994-04-22 7 312